Asston Pharmaceuticals Ltd Financials
Company Logo

Asston Pharmaceuticals Ltd Financial Statement

Asston Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Asston Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual15.59
Operating Expenses Annual13.04
Operating Profit Annual2.80
Interest Annual0.93
Depreciation0.05
Net Profit Annual1.36
Tax Annual0.46

Asston Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.12
Cash Flow from Operations-3.80
Cash Flow from Investing-0.01
Cash Flow from Financing3.69
Cash Flow at the End0.01

Asston Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)17.96
PBIT Margin (%)17.64
PBT Margin (%)-1.35
Net PROFIT Margin (%)8.72
Return On Networth / Equity (%)32.46
Return On Networth /Employed (%)26.61
Return On Assets (%)13.17
Total Debt / Equity (X)1.44
Asset Turnover Ratio (%)1.51

Asston Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1.09
Total Current Assets Annual18.34
Non Current Assets Annual1.92
Total Shareholders Funds Annual6.39
Total Assets Annual20.26

Asston Pharmaceuticals Ltd Earning Calls

No Data Availabe

FAQS on Asston Pharmaceuticals Ltd Financials

As of Jul 17, 2025, Asston Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Asston Pharmaceuticals Ltd is not with a debt-to-equity ratio of 0.68.

In FY 2024 , Asston Pharmaceuticals Ltd recorded a total revenue of approximately 25.04 Cr marking a significant milestone in the company's financial performance.

Asston Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.7% annually, respectively..

Asston Pharmaceuticals Ltd's current PE ratio is .

Asston Pharmaceuticals Ltd's ROCE averaged 29.1% from the FY ending March 2023 to 2025, with a median of 29.5%. It peaked at 37.0% in March 2025, reflecting strong capital efficiency over the period..

Asston Pharmaceuticals Ltd's latest EBIT is Rs. 6.65 Cr, surpassing the average EBIT of Rs. 3.84 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions